New Methionine-based P-toluenesulphonamoyl Carboxamide Derivatives as Antimicrobial and Antioxidant Agents: Design, Synthesis and Molecular Docking

Main Article Content

Melford Chuka Egbujor
Uchechukwu Chris Okoro


Aim: The reported emergence of drug resistant microbes and the prevalence of oxidative stress related diseases prompted the need for the development of new antimicrobial and antioxidant agents. The synthesis of methione-based sulphonamoyl carboxamides bearing aniline, pyridine and pyrimidine pharmacophores is reported.

Place and duration: Department of Industrial Chemistry, Renaissance University, Ugbawka, Enugu, 2018. 

Methodology: The p-toluenesulphonyl chloride reaction with methionine gave compound 3a which was acylated to afford compound 3b. Further chlorination and aminolysis of compound 3b gave the carboxamide (3c). Nickel catalysed reaction of the carboxamide with aryl/heteroaryl halides afforded compounds 3d-f in excellent yields. Characterization of compounds was done using H1-NMR, C13-NMR, FTIR and elemental analysis. Their antimicrobial, antioxidant activity and molecular docking were determined.

Results: Compounds 3a and 3e had the best antimicrobial activity with minimum inhibitory concentration (MIC) in the range of 0.6 – 0.9mg/ml and the highest antioxidant percentage inhibition (93.53% and 93.28% at 200µg/ml respectively) comparable with ascorbic acid (96.83% at 200µg/ml) and also the best IC50 values of 1.031 and 1.051µg/ml.

The molecular docking study, revealed that compounds 3a (TPSA = 83.47 Å2) could permeate blood-brain barriers. Compound 3e (-11.14 kcal/mol) had a better in silico antibacterial activity than penicillin (-10.89 kcal/mol) while compound 3a (-14.90kcal/mol) had a better antioxidant activity than α-tocopherol (-14.82 kcal/mol).

Conclusion: All the synthesized compounds were confirmed to be likely drugs and potential antimicrobial and antioxidant, agents.

Methionine, sulphonamides, carboxamides, molecular docking, antimicrobial activity, antioxidant activity

Article Details

How to Cite
Egbujor, M. C., & Okoro, U. C. (2019). New Methionine-based P-toluenesulphonamoyl Carboxamide Derivatives as Antimicrobial and Antioxidant Agents: Design, Synthesis and Molecular Docking. Journal of Pharmaceutical Research International, 28(1), 1-12.
Original Research Article


Jos WM. Vander Meer. The infectious disease challenges of our time. Front Public Health. 2013;1:7

Halliwell Barry. Oxidative stress and cancer: Have we moved forward. Biochem.J. 2007;401(1):1-11.

Hwang O. Role of oxidative stress in Parkinson’s disease. Exp Neurobiol. 2013;22(1):1-7.

Kock, MD, Jessup DA, Clark RK, Franti CE. Effects of Capture on biological parameters in free-ranging bibhorn: Evaluation of drop-net, drive-net, chemical immobilization and the net-gun. Journal of Widelife Diseases. 1987;23(4):641-651.

Shwartzman G. concerted antibiotic effect of penicillin, methionine, threonine and methionine sulfoxide upon Brucella, Eberthella, Salmonella, and shigella. Science. 1945;10;102(2641):148-50.

Garg RP, Qian XL, Alemany LB, Moran S Parry, RJ. Proc. Natl. Acad Sci, USA. 2008;105(18):6543-6547.

Tang L, Zhang YX, Hut Chinso CR. J. Bacteriol. 176(1a):6107-6119.

Gabriel Pizzino, et al. Oxidative Stress: Harms and benefits for human health. Oxidative Medicine and Cellular Longevity; 2017. Article ID8416763, 13 pages.

Shen Luo, Rodney L. Levine. Methionine in proteins defends against oxidative stress. FASEBJ. 2009;23(2):464-472.

Young VR. Adult amino acid requirements: The case for a major revision in recurrent recommendations. J. Nutri. 1994;124(8): 1517-1523.

Brosnana, JT, Brosnan ME. The sulfur-contaning amino acids. An overview. The Journal of Nutri. 2006;136(6):1636-1640.

Stipanuk MH, Ueki lori. Dealing with Methionine/homocystaine slfaur: Cysteine metabolism to taurine and in organic sulfure. Jour of Inherited Metabolic Disease. 2011;34(1):17-32.

Glaser CB, Fink AL. methionine oxidation, &-synuclein and Parkinson’s disease. Biochemica et Biophysica Acta (BBA)-Proteins and Proteomics. 2005;1703(2); 157-169.

Bales CW, Ritchie CS. Sarcopenia weight loss, nutritional fraility in the elderly. Annual Review of Nurtrition. 2002;22:309-323.

Kass EH. Bateriuria and the diagnosis of infections of the urinary tract. AMA Arch Intern Med. 1957;100(5):709-714.

Jing Ma et al. A polymorphism of the methonine sythase gene: Association with plasma folate, vitamin B12, Homocysteine, and colorectal cancer risk. Cancer Epidemiology, Biomarkers and prevention. 1999.57:1098-1102.

Cagnacci A, Volpe A. Relation of homocysteine, folate, and vitamin B12 to bone mineral density of post meno pausal women. Bone. 2003;33(6):956-959.

Raul SJ, More AH , Mahajan SS. Intl. J. of Research in Pharmacy and Chemistry. 2011;1(4):991.

Yelland MJ, Nikles CJ, McNairn N, Del Mar CB, Schluter PJ. Rheumatology. 2007;46:140.

Verhaeghe P, Azas N, Gasquet M, Hutter S. Ducros C. Bioorg. Med. Chem. Lett. 2008;18:401.

Jiao, ZG, He HQ, Zeng CC, Tan JJ, Hu LM, Wang CX. Molecules. 2010;15:1917.

Hans FC, Jawetz E. Basic and Chemical Pharmacology, Kat zung B.G (Ed) Appletonlange 1998;763.

Vardanyan, R, Hruby V. Synthesis of Essential Drugs. Amsterdam: Elsevier, 2006;8.

Shet PM, Vaidya VP, Mahadevan KM, Shivananda MK, Sreenivasa S, Vijayakumar GR. Synthesis, Characterisation and antimicrobial studies of novel Sulphonamides containing substitutednaphthofuroyl group. Research Journal of Chemical Sciences. 2013;3(1): 15-20.

Montalbetti CAGN, Falque V. Amide bond formation and peptide coupling. Tetrahedron. 2005;61:10852.

Roskoski R Jr. Sti-571: An Anticancer Protein-tyrosine Kinase Inhibitor. Biochem. Biophys. Res.Commu. 2003;309:717.

Ananthanarayanan VS, Tetreault S, Saint-Jean. A. J. Med. Chem. 1993;36: 1332.

Graul A, Castaner J. Atovarstatin Calcium. Drugs Future. 1997;22:968.

JU Y, Kuma D, Verma RS. Revisiting nucleophilic substifation reactions: Microwave- assisted synthesis of azides, thiocyanats and sulfones in an aqeous medium. Journal of Organic Chemistry. 2006;71(17):6697-6700.

JUY, Verma RS. Aqeous N hererocylization of primary anuries and hydrazines with dihalids microwave-assistant synthesis of N-azacycloalkanes, Isoindole, Pyrazole, Pyrazolidine and Phthalazine derivatives. Journal of Organic Chemistry. 2006;71(1):135-141.

Parke DV. The biochemistry of foreign compounds. Oxford: Pergamon press. 1968;224.

Garcia-valverde and Torroba T. Special issue: Sulfur-Nitrogen heterocycles. Molecules. 2005;10(2):318-320.

Mackison FW, Stricoff RS, Partridge LJ. JR. (Eds). NIOSH/OSHA. – Occupational Health Guideline for chemical Hazards. Pub No 81-123 (3vols). Washington DC US Government Printing office. 1981;3.

Browning E. Toxicity and metabolism of Industrial Solvents: New York: American Elsevier. 1996;304.

Lewis RJ. Sr (Ed). Hawley’s Condensed Chemical Dictionary.13.Ed. New York, NY: John Wiley & Sons Inc. 1997;42.

Jain KS, Chitre TS, Miniyar PB, et al. Biological and medical significance of Pyrimidine. Current Science. 2006;90(6): 793-803.

Infectious society of America, statement of the IDSA concerning “Bioshield II: Responding to a Disease Ever-Changing Threat”, IDSA, Alexandria, Va, USA; 2004.

Bradley JS, Guiclos R, Baragona, et al. Anti-infective research and development – problems, challenges, and solutions. The Lancet Infectious Diseases. 2007;7(1):68-78.

Coates AR and Hu, Y: Novel approaches to developing new antibiotics for bacterial infections. The British Journal of pharmacology. 2007;152(8)1147-1154.

Kimberlin, DW and Whitley RJ. Antiviral resistance: mechanisms chemical significance and future implications. Journal of Antimicrobial Chemotherapy. 1996;37(3):403-421.

Venanzi LM .Tetrahedral Nickel (11) complexes and the factors determining their formation. Journal of Chemical Society.1958;719-724.

Wiegand, Irith, Hilpert, Kai, Hancock, REW. Agar and Broth dilution methods to determine the minimal inhibitory concentration(MIC) of antimicrobial substances. Nature Protocols. 2008;3:163.

Blois MS. Antioxidant determinations by the use of a stable free radical. Nature. 1958;181:1199-1200.


Prabhakara V Choudary, GR Rao. Free amino acid pool in candida albicans contains higher levels of glycine and methionine than in non-pathogenic candida species. Microbios Letters. 1983;23(89): 35-39.

Lipinski CA, Lombardo L, Dominy BW, Feeney PJ. Adv Drug Deliv Rev. 2001;46: 3-26.

Verber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J.Med Chem. 2002;6:45(12):2615-23.

Zhao Y, Abraham MH, Lee J, Hersey A, Luscombe NC, Beck G, et al. Pharm Res. 2002;19:1446-1457.

Van de waterbeemd H, Carter RE, Grassy G, Kubinyi H, Martins YC, Tute MS and Willet, P. Grossory of terms used in computational drug design.1997;69(5): 1137-1152.